[
    {
        "content": "<p>A formulary can be thought of as composed of two distinct sets of data.<br>\n1) the list of drugs that are covered, together with associated tier information.<br>\n2) the specific cost-sharing (copays, coinsurance, drug specific deductibles, maximum cost per fill, etc) that a consumer pays</p>\n<p>Item 1 (the list) is currently contained in the FormularyDrugs list corresponding to a particular PlanID.  In practice, however, that list is used across a wide range of plans (e.g. all of CareFirst's individual market plans in the DMV/DC area). The current structure requires that list to be repeated across plans.  In current practice, the list is usually what is contained in the PDF document posted at link the FormularyURL field.  Ideally, this list would have an identifier (with versioning), so various parties can reference this drug list independently of a particular plan</p>\n<p>Item 2 is the cost-sharing for that particular plan.  Cost-sharing usually works at the level of a plan or product line of plans.  Thus there is less replication.</p>",
        "id": 185052047,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578429407
    },
    {
        "content": "<p>\"Legacy\" formularies (typically printable/PDF documents) that respond to the formulary URL.</p>\n<p>Drugs are often listed by class, then alphabetically within a class.  Many of these formularies use the convention of capitalizing and/or bolding brand names and putting generics in lowercase italics.</p>\n<p>Here are some examples of \"legacy\" formularies from the ACA and other markets:<br>\n<strong>Kaiser - ACA/Indiv Colorado</strong><br>\n<a href=\"https://healthy.kaiserpermanente.org/content/dam/kporg/mhc/drug-formulary1/co_marketplace_formulary_sec.pdf\" target=\"_blank\" title=\"https://healthy.kaiserpermanente.org/content/dam/kporg/mhc/drug-formulary1/co_marketplace_formulary_sec.pdf\">https://healthy.kaiserpermanente.org/content/dam/kporg/mhc/drug-formulary1/co_marketplace_formulary_sec.pdf</a><br>\nNo dose form or strength, no brand&lt;-&gt;generic (presumably this means brand drugs are available only with exception/prior auth)<br>\nIncludes tier numbers, no prices</p>\n<p><strong>Kaiser - HMO - Mid-Atlantic</strong><br>\n<a href=\"https://healthy.kaiserpermanente.org/static/health/pdfs/formulary/mid/mid_hmo_formulary.pdf\" target=\"_blank\" title=\"https://healthy.kaiserpermanente.org/static/health/pdfs/formulary/mid/mid_hmo_formulary.pdf\">https://healthy.kaiserpermanente.org/static/health/pdfs/formulary/mid/mid_hmo_formulary.pdf</a><br>\nNo dose form or strength, no tier numbers (tiers may not exist)</p>\n<p><strong>Kaiser - FEHB (federal employees) - Denver</strong><br>\n<a href=\"https://healthy.kaiserpermanente.org/content/dam/kporg/mhc/drug-formulary1/2020_FEHB_formulary_sec.pdf\" target=\"_blank\" title=\"https://healthy.kaiserpermanente.org/content/dam/kporg/mhc/drug-formulary1/2020_FEHB_formulary_sec.pdf\">https://healthy.kaiserpermanente.org/content/dam/kporg/mhc/drug-formulary1/2020_FEHB_formulary_sec.pdf</a><br>\nNo dose form or strength, no brand&lt;-&gt; generic<br>\nIncludes tier numbers (and prices- probably an exception because the FEHB has only one(ish) plan due to the way the FEHB program works).</p>\n<p>Bright Health Colorado - ACA/Indiv - Colorado<br>\n<a href=\"https://cdn1.brighthealthplan.com/docs/formulary/2020-co-ifp-formulary-en.pdf\" target=\"_blank\" title=\"https://cdn1.brighthealthplan.com/docs/formulary/2020-co-ifp-formulary-en.pdf\">https://cdn1.brighthealthplan.com/docs/formulary/2020-co-ifp-formulary-en.pdf</a><br>\nHas dose form and strength  </p>\n<p>UPMC - ACA/Indiv - PA<br>\n<a href=\"https://embed.widencdn.net/pdf/plus/upmc/hd4gndmd4k/2019-advantage-choice-pharmacy-benefit-guide_web.pdf\" target=\"_blank\" title=\"https://embed.widencdn.net/pdf/plus/upmc/hd4gndmd4k/2019-advantage-choice-pharmacy-benefit-guide_web.pdf\">https://embed.widencdn.net/pdf/plus/upmc/hd4gndmd4k/2019-advantage-choice-pharmacy-benefit-guide_web.pdf</a><br>\nHas does form but no strength<br>\nIncludes tier numbers</p>",
        "id": 185054036,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578430718
    },
    {
        "content": "<blockquote>\n<p>A formulary can be thought of as composed of two distinct sets of data.<br>\n1) the list of drugs that are covered, together with associated tier information.<br>\n2) the specific cost-sharing (copays, coinsurance, drug specific deductibles, maximum cost per fill, etc) that a consumer pays</p>\n<p>Item 1 (the list) is currently contained in the FormularyDrugs list corresponding to a particular PlanID. <br>\n...<br>\nItem 2 is the cost-sharing for that particular plan.</p>\n</blockquote>\n<p>I'm in another universe (EU) but just this seems very much \"insurance-centric\". Formularies have lots of information about the meds themselves, and their primary focus is/was supposedly clinical - about the composition and application of the drugs (posology, targets). <br>\nNot wanting to challenge your scope, because I know you have things like NCPDP formulary / benefits. Just just to make clear that in other places the formulary is about clinical first (hence the name Formulary).</p>",
        "id": 185055236,
        "sender_full_name": "Jose Costa Teixeira",
        "timestamp": 1578431494
    },
    {
        "content": "<p>Here's my proposal:<br>\nMake a \"Formulary Drug List\" object/resource that encapsulates whether drugs are covered, and what tier they are on.  This most closely resembles the PDF formularies that are the current legacy standard.<br>\nThis object/resource should have a global identifier that allows it to be publicly identified (similar to a plan's HIOS ID).</p>\n<p>Drugs should be specified in a cascading way:<br>\nA</p>\n<ul>\n<li>By brand name (RXNORM TTY=BN)</li>\n<li>\n<p>By ingredient (TTY=IN/MIN), provided that this ingredient unambiguously defines a drug product<br>\nB</p>\n</li>\n<li>\n<p>By dose form group (TTY=SCDG, SBDG)<br>\nC</p>\n</li>\n<li>\n<p>By drug (TTY=SCD,GPCK,SBD,BPCK)</p>\n</li>\n</ul>\n<p>A query to the resource would then resolve any drugs specified as A or B into C.  There could an exclusion mechanism to exclude some C's from the list derived from A or B.  Drugs could also explicitly specified as C (this is the current standard for ACA/Medicare formulary data submissions).</p>\n<p>The list should also handle the policy variants currently stated in the PDF formulary, e.g.:<br>\nAdvantage Choice requires you to use a generic version of the drug if one is available. This means that if you receive a brand-name drug when a generic is available, you must pay the brand copayment in addition to the retail cost difference between the brand-name and generic forms of the drug.</p>",
        "id": 185056433,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578432353
    },
    {
        "content": "<p>again apologies for input where not requested. in the US you may have it easy and it is maybe possible to have this as a hierarchical structure. But in fact the formulary is a graph of concepts. A polyhierarchical structure. And you mention 4 levels of products, there are more levels than 4.</p>",
        "id": 185057023,
        "sender_full_name": "Jose Costa Teixeira",
        "timestamp": 1578432718
    },
    {
        "content": "<p>Have you looked at using the List resource?</p>",
        "id": 185080650,
        "sender_full_name": "Lloyd McKenzie",
        "timestamp": 1578458188
    },
    {
        "content": "<p>(deleted)</p>",
        "id": 185118256,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578495004
    },
    {
        "content": "<blockquote>\n<p>I'm in another universe (EU) but just this seems very much \"insurance-centric\". Formularies have lots of information about the meds themselves, and their primary focus is/was supposedly clinical - about the composition and application of the drugs (posology, targets). <br>\nNot wanting to challenge your scope, because I know you have things like NCPDP formulary / benefits. Just just to make clear that in other places the formulary is about clinical first (hence the name Formulary).</p>\n</blockquote>\n<p>Good points.  One thing we were discussing is that the term \"formulary\" itself is quite overloaded.  Your feedback confirms this. I think we are trying to parse out some of the different meanings so we can figure out which resources are applicable for each.  Can you elaborate on some of the uses of a formulary that go with the definitions you have mind?</p>",
        "id": 185118474,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578495135
    },
    {
        "content": "<blockquote>\n<p>Have you looked at using the List resource?</p>\n</blockquote>\n<p>Thanks!  I just looked through the collection resources, and a List does seem like it could fit.  The idea of tracking changes is definitely valuable in this context.</p>",
        "id": 185122757,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578497271
    },
    {
        "content": "<p>Perhaps also good to discuss with the Catalog group. And Pharmacy. <span class=\"user-mention\" data-user-id=\"192166\">@Jean Duteau</span> has been spammed with requests, I presume that we should be closer to having a solution.</p>",
        "id": 185123211,
        "sender_full_name": "Jose Costa Teixeira",
        "timestamp": 1578497480
    },
    {
        "content": "<p>Let's use this as an example of a \"legacy\" formulary<br>\n<a href=\"https://embed.widencdn.net/pdf/plus/upmc/hd4gndmd4k/2019-advantage-choice-pharmacy-benefit-guide_web.pdf\" target=\"_blank\" title=\"https://embed.widencdn.net/pdf/plus/upmc/hd4gndmd4k/2019-advantage-choice-pharmacy-benefit-guide_web.pdf\">https://embed.widencdn.net/pdf/plus/upmc/hd4gndmd4k/2019-advantage-choice-pharmacy-benefit-guide_web.pdf</a></p>",
        "id": 185127795,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578499674
    },
    {
        "content": "<blockquote>\n<p>Perhaps also good to discuss with the Catalog group. And Pharmacy. <span class=\"user-mention silent\" data-user-id=\"192166\">Jean Duteau</span> has been spammed with requests, I presume that we should be closer to having a solution.</p>\n</blockquote>\n<p>Makes sense.  Two comments.:<br>\n1) The Catalog concept you describe is really beyond what we're working on (now) for this resource<br>\n2) The RxNorm coding scheme includes the polyhierarchical relationships you describe.  If there exists a need to expose some of these relationships via FHIR, it would be good raise that with Pharmacy</p>",
        "id": 185128016,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578499795
    },
    {
        "content": "<p>Catalog was made for polyhierarchical relations. I think MedicationKnowledge resource does not have the flexibility needed for that</p>",
        "id": 185128403,
        "sender_full_name": "Jose Costa Teixeira",
        "timestamp": 1578500027
    },
    {
        "content": "<p>here's a basic scope (just unidimensional). this gets more interesting when we start putting the supply chain dimension in place <br>\n(as in: some drugs come from different providers, so they may get different ERP logistic product codes... Some drugs are available in the pharmacy, others are on request, so they may get some different  logistic IDs..)</p>",
        "id": 185131355,
        "sender_full_name": "Jose Costa Teixeira",
        "timestamp": 1578501844
    },
    {
        "content": "<p><a href=\"user_uploads/10155/zu6Bm1NYIDPorRsmKfg33Fy_/dPHTQuCm58Rl_HM7NKymVbL76RM3TJ0OOuLTzIQQT3WqYaRMGd_yaiN5sDQrJ11yaoVlEIVduABbkE5TMLXL-aap3ZVhBXLhBADt6vPabE-B5XTvbeiNaYmdDu1R84ZpAyfeasSJz8OXnu7o0pXE2yfXMpNmy0vrrzHLIrjbvbvj5foOrJXdoiMpjC.png\" target=\"_blank\" title=\"user_uploads/10155/zu6Bm1NYIDPorRsmKfg33Fy_/dPHTQuCm58Rl_HM7NKymVbL76RM3TJ0OOuLTzIQQT3WqYaRMGd_yaiN5sDQrJ11yaoVlEIVduABbkE5TMLXL-aap3ZVhBXLhBADt6vPabE-B5XTvbeiNaYmdDu1R84ZpAyfeasSJz8OXnu7o0pXE2yfXMpNmy0vrrzHLIrjbvbvj5foOrJXdoiMpjC.png\">dPHTQuCm58Rl_HM7NKymVbL76RM3TJ0OOuLTzIQQT3WqYaRMGd_yaiN5sDQrJ11yaoVlEIVduABbkE5TMLXL-aap3ZVhBXLhBADt6vPabE-B5XTvbeiNaYmdDu1R84ZpAyfeasSJz8OXnu7o0pXE2yfXMpNmy0vrrzHLIrjbvbvj5foOrJXdoiMpjC.png</a></p>\n<div class=\"message_inline_image\"><a href=\"user_uploads/10155/zu6Bm1NYIDPorRsmKfg33Fy_/dPHTQuCm58Rl_HM7NKymVbL76RM3TJ0OOuLTzIQQT3WqYaRMGd_yaiN5sDQrJ11yaoVlEIVduABbkE5TMLXL-aap3ZVhBXLhBADt6vPabE-B5XTvbeiNaYmdDu1R84ZpAyfeasSJz8OXnu7o0pXE2yfXMpNmy0vrrzHLIrjbvbvj5foOrJXdoiMpjC.png\" target=\"_blank\" title=\"dPHTQuCm58Rl_HM7NKymVbL76RM3TJ0OOuLTzIQQT3WqYaRMGd_yaiN5sDQrJ11yaoVlEIVduABbkE5TMLXL-aap3ZVhBXLhBADt6vPabE-B5XTvbeiNaYmdDu1R84ZpAyfeasSJz8OXnu7o0pXE2yfXMpNmy0vrrzHLIrjbvbvj5foOrJXdoiMpjC.png\"><img src=\"user_uploads/10155/zu6Bm1NYIDPorRsmKfg33Fy_/dPHTQuCm58Rl_HM7NKymVbL76RM3TJ0OOuLTzIQQT3WqYaRMGd_yaiN5sDQrJ11yaoVlEIVduABbkE5TMLXL-aap3ZVhBXLhBADt6vPabE-B5XTvbeiNaYmdDu1R84ZpAyfeasSJz8OXnu7o0pXE2yfXMpNmy0vrrzHLIrjbvbvj5foOrJXdoiMpjC.png\"></a></div>",
        "id": 185131387,
        "sender_full_name": "Jose Costa Teixeira",
        "timestamp": 1578501862
    },
    {
        "content": "<blockquote>\n<p>here's a basic scope (just unidimensional). this gets more interesting when we start putting the supply chain dimension in place <br>\n(as in: some drugs come from different providers, so they may get different ERP logistic product codes... Some drugs are available in the pharmacy, others are on request, so they may get some different  logistic IDs..)</p>\n</blockquote>\n<p>I think this is out of scope of the definition of formulary we're working under.  Wish I knew how to advise you where to go.</p>",
        "id": 185137257,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578505258
    },
    {
        "content": "<p>That is fine. I don't want to challenge your scope, just raise awareness that things in other places get tricky.</p>",
        "id": 185137539,
        "sender_full_name": "Jose Costa Teixeira",
        "timestamp": 1578505439
    },
    {
        "content": "<p>BTW that image is assuming one country. imagine if there were a federation of 27-1 countries all with their codes, their levels, their requirements.. I just wanted to say this is fun, pick from that what you need. I understand the needs in the US are focused (at least in the beginning) on the insurance stuff.</p>",
        "id": 185137691,
        "sender_full_name": "Jose Costa Teixeira",
        "timestamp": 1578505535
    },
    {
        "content": "<blockquote>\n<p>That is fine. I don't want to challenge your scope, just raise awareness that things in other places get tricky.</p>\n</blockquote>\n<p>Thanks.  I guess the question is whether there is overlap between the concept of a formulary you are working under and the one we are working under.</p>",
        "id": 185139534,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578506649
    },
    {
        "content": "<p>Here is an ERD for the proposed scheme <a href=\"/user_uploads/10155/SirS9YkZZE7jVjUY345Vj52O/FHIR-Drug-Formulary-ERD.png\" target=\"_blank\" title=\"FHIR-Drug-Formulary-ERD.png\">FHIR-Drug-Formulary-ERD.png</a></p>\n<div class=\"message_inline_image\"><a href=\"/user_uploads/10155/SirS9YkZZE7jVjUY345Vj52O/FHIR-Drug-Formulary-ERD.png\" target=\"_blank\" title=\"FHIR-Drug-Formulary-ERD.png\"><img src=\"/user_uploads/10155/SirS9YkZZE7jVjUY345Vj52O/FHIR-Drug-Formulary-ERD.png\"></a></div>",
        "id": 185150855,
        "sender_full_name": "Eric Ellsworth",
        "timestamp": 1578513633
    },
    {
        "content": "<p><span class=\"user-mention\" data-user-id=\"257172\">@Eric Ellsworth</span> - your proposed scheme is not that different than the current IG.  Remember the IG is an interface to data, not the way the data will be persisted in whatever database holds the data.   So, I don't think some of the 'redundancies' that you point out are significant.</p>\n<p>In general, much of the feedback in this thread would have been very useful last spring or during the ballot for STU1...now they will serve as fodder for the STU2 discussions, hopefully after there is some experience suffering from, er using, the STU1 which is about to be published.</p>\n<p>Keep in mind that this IG is meant to be a consumer facing formulary that replaces the myriad of different PDFs and web sites that plans provide today.  It is <em>NOT</em> meant to support e-prescribing or RTPBC, nor is it meant to replace/recapitulate RxNorm.   I think the level of detail provided is appropriate for a consumer shopping for a drug plan, or trying to understand their plan's formulary.   The alternatives was not intended to support clinical decision making, but rather to provide a way to link \"obvious\" alternatives -- e.g., generic alternatives to brand name drugs.   In the few plan formularies that I found that included alternative information, this is how alternatives were used.</p>",
        "id": 185705638,
        "sender_full_name": "Saul Kravitz",
        "timestamp": 1579100580
    }
]